BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//FQHC Talent//The Record//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:FQHC Talent — Precios de medicamentos 340B
REFRESH-INTERVAL;VALUE=DURATION:PT24H
X-PUBLISHED-TTL:PT24H
BEGIN:VEVENT
UID:intel:amgen-340b-visit-claims-data-request-november-15-2026@fqhctalent.
 com
DTSTAMP:20261111T000000Z
DTSTART;VALUE=DATE:20261115
DTEND;VALUE=DATE:20261116
SUMMARY:Amgen pedirá datos de visitas de 340B desde el 15 de noviembre
DESCRIPTION:Amgen pedirá datos de visitas de 340B desde el 15 de noviembre
 \n\nhttps://www.amgen.com/newsroom/company-statements/340b-program-integri
 ty-policy-update
URL:https://www.amgen.com/newsroom/company-statements/340b-program-integrit
 y-policy-update
CATEGORIES:DEADLINE
STATUS:CONFIRMED
END:VEVENT
BEGIN:VEVENT
UID:intel:aha-v-kennedy-court-sets-november-18-hearing-340b-rebate-pilot-no
 vember-2026@fqhctalent.com
DTSTAMP:20261111T000000Z
DTSTART;VALUE=DATE:20261118
DTEND;VALUE=DATE:20261119
SUMMARY:Audiencia en Maine sobre la solicitud de los hospitales de bloquear
  el piloto de reembolsos 340B
DESCRIPTION:Audiencia en Maine sobre la solicitud de los hospitales de bloq
 uear el piloto de reembolsos 340B\n\nhttps://www.courtlistener.com/docket/
 74942409/american-hospital-association-v-kennedy/
URL:https://www.courtlistener.com/docket/74942409/american-hospital-associa
 tion-v-kennedy/
CATEGORIES:HEARING
STATUS:CONFIRMED
END:VEVENT
BEGIN:VEVENT
UID:intel:cms-part-d-pharmacy-contracting-standards-rfi-340b-sept-2026@fqhc
 talent.com
DTSTAMP:20261111T000000Z
DTSTART;VALUE=DATE:20261123
DTEND;VALUE=DATE:20261124
SUMMARY:Vencen los comentarios sobre la solicitud de información de CMS ac
 erca de los contratos de farmacia de la Parte D\, incluidos los reclamos 3
 40B
DESCRIPTION:Vencen los comentarios sobre la solicitud de información de CM
 S acerca de los contratos de farmacia de la Parte D\, incluidos los reclam
 os 340B\n\nhttps://www.federalregister.gov/documents/2026/09/24/2026-19535
 /request-for-information-medicare-part-d-reasonable-and-relevant-pharmacy-
 contracting-standards
URL:https://www.federalregister.gov/documents/2026/09/24/2026-19535/request
 -for-information-medicare-part-d-reasonable-and-relevant-pharmacy-contract
 ing-standards
CATEGORIES:DEADLINE
STATUS:CONFIRMED
END:VEVENT
BEGIN:VEVENT
UID:state-intel:ms-cd72f4943d9c@fqhctalent.com
DTSTAMP:20261111T000000Z
DTSTART;VALUE=DATE:20261127
DTEND;VALUE=DATE:20261128
SUMMARY:Vence la respuesta de Misisipi a la petición de Novartis ante la C
 orte Suprema sobre la ley 340B
DESCRIPTION:Vence la respuesta de Misisipi a la petición de Novartis ante 
 la Corte Suprema sobre la ley 340B\n\nhttps://www.supremecourt.gov/search.
 aspx?filename=/docket/docketfiles/html/public/26-457.html
URL:https://www.supremecourt.gov/search.aspx?filename=/docket/docketfiles/h
 tml/public/26-457.html
CATEGORIES:DEADLINE
STATUS:CONFIRMED
END:VEVENT
BEGIN:VEVENT
UID:intel:cms-globe-model-final-rule-340b-units-excluded-october-2026@fqhct
 alent.com
DTSTAMP:20261111T000000Z
DTSTART;VALUE=DATE:20261130
DTEND;VALUE=DATE:20261201
SUMMARY:Entra en vigor el modelo GLOBE de reembolsos de medicamentos de la 
 Parte B de Medicare\, que deja fuera los reclamos 340B
DESCRIPTION:Entra en vigor el modelo GLOBE de reembolsos de medicamentos de
  la Parte B de Medicare\, que deja fuera los reclamos 340B\n\nhttps://www.
 federalregister.gov/documents/2026/10/02/2026-20281/global-benchmark-for-e
 fficient-drug-pricing-globe-model
URL:https://www.federalregister.gov/documents/2026/10/02/2026-20281/global-
 benchmark-for-efficient-drug-pricing-globe-model
CATEGORIES:EFFECTIVE
STATUS:CONFIRMED
END:VEVENT
BEGIN:VEVENT
UID:advocacy:wa-340b-manufacturer-lawsuit-novartis-abbvie-2026@fqhctalent.c
 om
DTSTAMP:20261111T000000Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:Audiencia del Noveno Circuito sobre la apelación de las farmacéut
 icas contra la ley 340B de farmacias por contrato de Washington
DESCRIPTION:Audiencia del Noveno Circuito sobre la apelación de las farmac
 éuticas contra la ley 340B de farmacias por contrato de Washington\n\nhtt
 ps://www.courtlistener.com/docket/73487650/abbvie-inc-et-al-v-brown-et-al/
URL:https://www.courtlistener.com/docket/73487650/abbvie-inc-et-al-v-brown-
 et-al/
CATEGORIES:HEARING
STATUS:CONFIRMED
END:VEVENT
BEGIN:VEVENT
UID:intel:cms-4214-p-medicare-pbm-340b-reporting-proposed-rule-october-2026
 @fqhctalent.com
DTSTAMP:20261111T000000Z
DTSTART;VALUE=DATE:20261215
DTEND;VALUE=DATE:20261216
SUMMARY:CMS propone que administradores de beneficios de farmacia informen 
 acuerdos 340B
DESCRIPTION:CMS propone que administradores de beneficios de farmacia infor
 men acuerdos 340B\n\nhttps://www.govinfo.gov/content/pkg/FR-2026-10-20/htm
 l/2026-21420.htm
URL:https://www.govinfo.gov/content/pkg/FR-2026-10-20/html/2026-21420.htm
CATEGORIES:DEADLINE
STATUS:CONFIRMED
END:VEVENT
BEGIN:VEVENT
UID:intel:cms-medicare-part-d-340b-claims-repository-live-october-2026@fqhc
 talent.com
DTSTAMP:20261111T000000Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:Fecha prevista para presentar de forma voluntaria los reclamos 340B
  de la Parte D del 1 de enero al 30 de septiembre de 2026
DESCRIPTION:Fecha prevista para presentar de forma voluntaria los reclamos 
 340B de la Parte D del 1 de enero al 30 de septiembre de 2026\n\nhttps://w
 ww.cms.gov/initiatives/medicare-prescription-drug-affordability/overview/m
 edicare-inflation-rebate-program
URL:https://www.cms.gov/initiatives/medicare-prescription-drug-affordabilit
 y/overview/medicare-inflation-rebate-program
CATEGORIES:DEADLINE
STATUS:TENTATIVE
END:VEVENT
BEGIN:VEVENT
UID:intel:hrsa-approves-ten-manufacturer-340b-rebate-plans-october-2026@fqh
 ctalent.com
DTSTAMP:20261111T000000Z
DTSTART;VALUE=DATE:20270101
DTEND;VALUE=DATE:20270102
SUMMARY:Empiezan los reembolsos de los planes 340B que HRSA aprobó para di
 ez fabricantes de medicamentos
DESCRIPTION:Empiezan los reembolsos de los planes 340B que HRSA aprobó par
 a diez fabricantes de medicamentos\n\nhttps://www.hrsa.gov/opa/340b-model-
 pilot-program
URL:https://www.hrsa.gov/opa/340b-model-pilot-program
CATEGORIES:EFFECTIVE
STATUS:CONFIRMED
END:VEVENT
BEGIN:VEVENT
UID:compliance:cms-part-d-340b-claims-reporting-2027@fqhctalent.com
DTSTAMP:20261111T000000Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:Reclamaciones 340B de la Parte D de Medicare: primer reporte obliga
 torio
DESCRIPTION:Reclamaciones 340B de la Parte D de Medicare: primer reporte ob
 ligatorio\n\nhttps://www.federalregister.gov/documents/2026/11/09/2026-227
 43/medicare-and-medicaid-programs-cy-2027-payment-policies-under-the-physi
 cian-fee-schedule-and-other
URL:https://www.federalregister.gov/documents/2026/11/09/2026-22743/medicar
 e-and-medicaid-programs-cy-2027-payment-policies-under-the-physician-fee-s
 chedule-and-other
CATEGORIES:DEADLINE
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR